Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21123186 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure
Conditions: Acute Decompensated Heart Failure;   Congestive Heart Failure
Interventions: Drug: Aliskiren;   Drug: Placebo

Indicates status has not been verified in more than two years